WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Stock Ownership - Who owns Arbutus Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arbutus Biopharma Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David C. HastingsChief Financial Officer2025-02-0422,183$3.28
$72.83kSell
Michael J. McElhaughInterim President CEO2025-02-0423,790$3.28
$78.10kSell
J. Christopher NaftzgerGeneral Counsel and CCO2025-02-0411,333$3.28
$37.21kSell
Karen SimsChief Medical Officer2025-02-0419,348$3.28
$63.52kSell
Keith S. ManchesterDirector2024-08-148,846$3.69
$32.63kSell
Keith S. ManchesterDirector2024-08-1454,915$0.56
$30.75kBuy

1 of 1

ABUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABUS insiders and whales buy or sell their stock.

ABUS Shareholders

What type of owners hold Arbutus Biopharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roivant Sciences Ltd20.29%38,847,462$122.37MInsider
Matthew Gline20.29%38,847,462$122.37MInsider
Dexxon Holdings Ltd16.73%32,027,080$100.89MInsider
Morgan Stanley11.80%22,586,918$71.15MInstitution
Vivek Ramaswamy8.39%16,068,455$50.62MInsider
Patrick MacHado8.36%16,013,540$50.44MInsider
Viking Global Performance LLC8.36%16,013,540$50.44MInsider
Andrew Lo8.36%16,013,540$50.44MInsider
Viking Global Investors LP8.36%16,013,540$50.44MInsider
Viking Global Equities Master Ltd8.36%16,013,540$50.44MInsider

1 of 3

ABUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABUS27.17%72.83%Net SellingNet Selling
XERS42.65%15.85%Net SellingNet Selling
ARVN77.41%22.59%Net SellingNet Selling
KALV57.73%42.27%Net BuyingNet Buying
ANAB45.45%54.55%Net BuyingNet Buying
View Top Biotech Stocks

Arbutus Biopharma Stock Ownership FAQ

Who owns Arbutus Biopharma?

Arbutus Biopharma (NASDAQ: ABUS) is owned by 54.18% institutional shareholders, 145.25% Arbutus Biopharma insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Arbutus Biopharma shareholder, owning 38.85M shares representing 20.29% of the company. Roivant Sciences Ltd's Arbutus Biopharma shares are currently valued at $124.70M.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.